# A Phase 3 Trial of JKN2401 Injection in COPD

> **NCT07330310** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Joincare Pharmaceutical Group Industry Co., Ltd** · enrollment: 888 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **BIOLOGICAL:** JKN2401 Injection
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07330310
- **Lead sponsor:** Joincare Pharmaceutical Group Industry Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2027-09
- **Final completion:** 2027-11
- **Target enrollment:** 888 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07330310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07330310, "A Phase 3 Trial of JKN2401 Injection in COPD". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT07330310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*